Перейти к основной навигации
Перейти к поиску
Перейти к основному содержанию
Сортировать по:
INIS
patients
100%
diseases
89%
kazakhstan
57%
reviews
49%
data
46%
risks
42%
proteins
40%
cancer
38%
populations
34%
levels
34%
women
31%
mortality
28%
humans
27%
genes
26%
kidneys
25%
children
23%
control
23%
hospitals
23%
comparative evaluations
22%
management
21%
covid-19
19%
therapy
19%
death
19%
surgery
19%
hiv
19%
heterochromatin
17%
drugs
17%
tissues
15%
inflammation
13%
values
13%
pain
13%
tumors
13%
mice
13%
pregnancy
12%
viruses
12%
genetics
12%
females
12%
saudi arabia
11%
pediatrics
11%
stem cells
11%
adults
11%
epidemiology
11%
losses
11%
assessments
11%
interventions
11%
males
10%
injuries
10%
applications
10%
people
10%
liver
9%
hepatitis
9%
screening
9%
design
9%
blood
9%
interactions
9%
asia
9%
surveys
9%
histones
9%
detection
9%
diabetes mellitus
9%
vaccines
9%
in vitro
8%
attitudes
8%
concentration
8%
income
8%
coronaviruses
8%
distribution
8%
units
8%
universities
8%
sex
7%
learning
7%
receptors
7%
policy
7%
chromatin
7%
information
7%
doses
7%
pakistan
7%
cost
7%
sampling
7%
wounds
7%
evaluation
7%
regulations
7%
healing
6%
antigens
6%
antibodies
6%
quality of life
6%
guidelines
6%
education
6%
biological markers
6%
glucose
6%
dna
6%
correlations
6%
antibiotics
6%
ovaries
6%
tuberculosis
6%
etiology
6%
molecules
6%
medicine
6%
tools
6%
nervous system diseases
6%
Medicine and Dentistry
Global Disease Burden
24%
Prevalence
17%
Diseases
12%
Disability Adjusted Life Years
8%
Chronic Kidney Disease
8%
COVID-19
6%
Cohort Effect
6%
Systematic Review
6%
Meta-Analysis
5%
Mortality Rate
5%
Pediatrics
5%
Keyphrases
Kazakhstan
16%
Global Burden
9%
Global Burden of Disease Study
8%
Regional Burden
8%
COVID-19
8%
National Burden
8%
Heterochromatin Proteins
6%
Meta-analysis
6%
Risk Factors
5%